Pharmaceutical preparation comprising recombinant HcG

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9676835
SERIAL NO

14283904

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include α2,3, α2,6, and, optionally, α2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FERRING B V2132 JX HOOFDDORP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cottingham, Ian St. Prex, CH 19 68
Plaksin, Daniel St. Prex, CH 28 205
White, Richard Boyd San Diego, US 9 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 13, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00